Inhibition of the oxidation of the urinary bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine by pyrazole and 4-substituted pyrazoles.
Irving
C C
CC
Veterans Administration Medical Center, Memphis, TN.
Daniel
D S
DS
D000818:Animals; D002085:Butylhydroxybutylnitrosamine / Q000378:metabolism*; D000077604:Fomepizole; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism; D008297:Male; D009243:NAD / Q000378:metabolism; D009602:Nitrosamines / Q000378:metabolism*; D010084:Oxidation-Reduction / Q000187:drug effects; D011720:Pyrazoles / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D001743:Urinary Bladder / Q000378:metabolism*
D009602:Nitrosamines; D011720:Pyrazoles; D009243:NAD; C000318:4-bromopyrazole; D002085:Butylhydroxybutylnitrosamine; C031280:pyrazole; D000077604:Fomepizole